Document:

Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (this “Agreement”), dated as of July 7, 2016 (the “Effective Date”), is entered into between Interlink Electronics, Inc., a Delaware corporation with principal offices located at 31248 Oak Crest Drive, Suite 110, Westlake Village, California 91361, (“Interlink Electronics” or the “Company”) and Steven N. Bronson, an individual residing in South Carolina (“Executive”) (each a “Party” and collectively, the “Parties”).

 

W I T N E S S E T H:

 

WHEREAS, Interlink Electronics desires to employ Executive, and Executive is willing to accept such employment on such terms and conditions as set forth below.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement, Interlink Electronics and Executive agree as follows:

 

1.                                      Employment. Interlink Electronics hereby employs Executive as its Chairman and Chief Executive Officer, subject to the terms and conditions set forth in this Agreement.

 

2.                                      Term. The term of this Agreement shall commence on July 7, 2016, and terminate on July 7, 2017 (the “Term”), subject to earlier termination pursuant to the provisions herein. The Term of this Agreement shall automatically renew for additional one year periods unless the Company or Executive provides written notice to the other party that the Agreement shall not be renewed at least thirty (30) days prior to the renewal date.

 

3.                                      Duties and Location. Executive shall serve as Chairman and Chief Executive Officer and shall perform all duties commensurate with his positions and as may be assigned to him by the Board of Directors of the Company. It is understood that Executive will not devote his full business time and energies to the business and affairs of the Company, however Executive shall use his best efforts, skills and abilities to promote the interests of the Company and to diligently and competently perform the duties of his positions for the Company. Executive will be based in Charleston, South Carolina, but will travel as necessary to fulfill his duties and responsibilities. Executive is eligible for reimbursement of related and necessary office and travel expenses consistent with Sections 4.2 and 5.

 

4.                                      Compensation and Benefits.

 

4.1                               Compensation. During the term of this Agreement, as compensation for the satisfactory performance of all duties to be performed by Executive hereunder, Interlink Electronics shall pay Executive a base salary of $300,000 per annum.  The base salary shall be payable in installments throughout the year in the same manner and at the same times the Company pays base salaries to similarly situated executive officers of the Company, but in any event, no less frequently than monthly.

 

4.2                               Residential and Travel Accommodations. The Company acknowledges that the Executive resides in Charleston, South Carolina and that he shall periodically commute to the Company’s principal offices in Westlake Village, California.  Accordingly, the Company shall provide Executive residential accommodations within the following California counties:

 

 

Ventura, Los Angeles or Santa Barbara. Prior to securing residential accommodations the Executive shall advise the Company’s Compensation Committee of the cost of the residential accommodations. The Company shall also pay for all of Executive’s travel expenses in commuting to the Company’s principal office.

 

4.3                               Bonus Compensation. Executive shall be entitled to earn and receive bonus compensation provided that certain performance goals are achieved by the Company. Bonuses shall be granted in accordance with a bonus plan to be adopted by the Company, the terms and conditions of which shall be determined by the Company’s Compensation Committee.

 

4.4                               Executive Benefit Plans. The Executive shall be permitted during the Term to participate in the Company’s medical plans, life and long term disability insurance plans and retirement plans pursuant to their terms and conditions. Executive shall be entitled to participate in any other benefit plan offered by the Company to its executives during the Term of this Agreement.

 

5.                                      Reimbursement of Business Expenses. During the term of this Agreement, upon submission of proper invoices, receipts or other supporting documentation satisfactory to Interlink Electronics and in specific accordance with such guidelines as may be established from time to time, Executive shall be reimbursed by Interlink Electronics for all reasonable business expenses actually and necessarily incurred by Executive on behalf of Interlink Electronics in connection with Executive’s performance of services under this Agreement.

 

6.                                      Representations as to Employability.

 

6.1                               Absence of Prior Restrictions. Executive represents and warrants that Executive is not party to, or bound by, any agreement or commitment, or subject to any restriction, including, but not limited to agreements related to previous employment containing confidentiality, non-solicitation, non-poaching or non-compete covenants, which would adversely affect the business of Interlink Electronics or Executive’s performance of duties under this Agreement.

 

6.2                               Absence of Third Party Proprietary Information. Executive represents and warrants that Executive is not in possession of and will not bring onto the Company’s premises or access or utilize any proprietary information of any prior employer or other third-party that Executive is not permitted to have. Executive represents, further, that Executive will be able to fulfill Executive’s duties hereunder without such proprietary information by utilizing only information that is generally available in the public domain or the rightful property of Executive or the Company.

 

7.                                      Confidentiality and Proprietary Information.

 

7.1                               Non-Disclosure. During the course of Executive’s employment with Interlink Electronics, Executive will learn of Confidential Information (as defined below) and Executive may develop Confidential Information on behalf of Interlink Electronics. Executive agrees that Executive will not use or disclose to any Person (except as required by applicable law or for the proper performance of Executive’s duties and responsibilities for Interlink Electronics) any Confidential Information obtained or created by Executive incident to Executive’s

 

2

 

employment or any other association with Interlink Electronics. Executive understand that this restriction shall continue to apply after Executive’s employment terminates, regardless of the reason for such termination.

 

7.2                               Protection of Information. All information, trade secrets, data, documents, records and files, in any kind of media, relating to the business (whether past, present or future) of Interlink Electronics (“Confidential Information”), whether or not prepared by Executive, shall be the sole and exclusive property of Interlink Electronics. Executive agrees to safeguard all Confidential Information and to surrender to Interlink Electronics, at the time Executive’s employment terminates or at such earlier time as requested, all tangible forms of Confidential Information of Interlink Electronics then in Executive’s possession or control, and to destroy or retrieve any copies, such that no Confidential Information which was at any time in Executive’s possession or control will exist in tangible form other than what Executive have turned over to Interlink Electronics or destroyed. Notwithstanding any other provisions of this Agreement, pursuant to 18 USC § 1833(b), Executive will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made: (i) solely for the purpose of reporting or investigating a suspected violation of law and in confidence to a federal, state, or local government official (either directly or indirectly) or to an attorney; or (ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.

 

7.3                               Work for Hire/Assignment. Executive will promptly disclose to Interlink Electronics all designs, software, computer code, processes, inventions, improvements, discoveries and other information related in any way to the business of Interlink Electronics (collectively “Developments”) conceived, developed or acquired by Executive alone or with others during the term of this Agreement, whether or not conceived during regular working hours, through the use of Company time, material or facilities or otherwise. All such Developments shall be considered “work for hire” and Interlink Electronics shall be the sole and exclusive owner of such Developments. Additionally, Executive hereby agrees to assign, transfer, and convey to Interlink Electronics any and all rights and/or interest Executive may have in the Developments. The Parties acknowledge that the assignment under this Agreement does not apply to any development for which no equipment, supplies, facility, or trade secret information of the Company was used and which was developed entirely on Executive’s own time, and (a) which does not relate (i) directly to the business of Interlink Electronics or (ii) to its actual or demonstrably anticipated research or development; or (b) which does not result from any work performed by Executive for the Interlink Electronics.

 

8.                                      Application of IRC Section 409A.

 

8.1                               If Executive is a “specified employee” within the meaning of Internal Revenue Code (“IRC”) Section 409A(a)(2)(B)(i) and any payment required to be made or benefit required to be provided pursuant to this Agreement is subject to IRC Section 409A and not exempt from those requirements under any applicable regulations or other guidance of general applicability, then any such payment otherwise payable on account of Employee’s separation from service during the period service ending on the date that is six (6) months after the separation from service shall be paid in a lump sum on the date that is six (6) months after Executive’s separation from service instead of the date on which it would otherwise be paid;

 

3

 

provided, however, that deferred compensation to which Executive is entitled under this Agreement need not be delayed under this subparagraph to the extent those payments would comply with the requirements of Treasury Regulations Section 1.409A-l(b)(9)(iii), which generally requires that the total of such payments not exceed two (2) times the lesser of (1) Executive’s annualized compensation based on his annual rate of pay in the year before the Executive’s separation from service or (2) the Code Section 401(a)(l 7) limit applicable to qualified plans during the year of Executive’s separation from service, In determining whether Executive is a “specified employee” Interlink Electronics (or its delegate) may, but need not, elect in writing, subject to applicable limitations under IRC Section 409A, any of the special effective rules prescribed in Treasury Regulation Section 1.409A-l(i).

 

8.2                               To the extent applicable, it is intended that this Agreement comply with the provisions of IRC Section 409A, so as to prevent inclusion in gross income of any amounts payable or benefits provided hereunder in a taxable year that is prior to the taxable year or years in which such amounts or benefits would otherwise actually be distributed, provided or otherwise made available to Executive. This Agreement shall be construed, administered, and governed in a manner consistent with this intent and the following provisions of this paragraph shall control over any contrary provisions of this Agreement.

 

8.3                               Payments and benefits under this Agreement payable upon Executive’s termination or severance of employment with Interlink Electronics that constitute deferred compensation under IRC Section 409A shall not be paid or provided prior to Executive’s “separation from service” within the meaning of IRC Section 409A.

 

8.4                               For purposes of IRC Section 409A, the right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments so that each payment is designated as a separate payment for purposes of IRC Section 409A.

 

8.5                               References in this Agreement to IRC Section 409A include both that Section of the IRC itself and any guidance promulgated thereunder.

 

8.6                               Interlink Electronics makes no representation or warranty and shall have no liability to Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to IRC Section 409A but do not satisfy an exemption from, or the conditions of, such Section.

 

9.                                      Termination. This Agreement may be terminated prior to the expiration of the Term set forth in Section 2 upon the occurrence of any of the events set forth in, and subject to the terms of, this Section 9.

 

9.1                               Voluntarily. Executive may terminate this Agreement at any time by giving no less than thirty (30) days written notice to Interlink Electronics

 

9.2                               Death. This Agreement will terminate immediately and automatically upon Executive’s death.

 

9.3                               Disability. This Agreement may be terminated at Interlink Electronics’ option, immediately upon notice to the Executive, if Executive shall suffer a permanent

 

4

 

disability. For the purposes of this Agreement, the term “permanent disability” shall mean Executive’s inability to perform Executive’s duties under this Agreement for a period of ninety (90) consecutive days due to illness, accident or any other physical or mental incapacity, as determined by the Board of Directors of Interlink Electronics. In the event that a dispute arises with respect to Executive’s disability, the parties shall each select a duly licensed medical doctor to make such a determination. If the two doctors so selected cannot agree on a determination, they will mutually select a third duly licensed medical doctor and the decision of the majority of the three doctors will be binding.

 

9.4                               Termination by Interlink Electronics for Cause. Interlink Electronics may terminate this Agreement upon thirty (30) days written notice to Executive for “Cause,” as defined below. “Cause” shall mean (i) the willful and material breach or the material failure by Executive to perform Executive’s duties and obligations under this Agreement, provided Executive does not cure such breach within thirty (30) days of Executive’s receipt of written notice of such breach, (ii) Executive’s commission of a material act of dishonesty or gross negligence in the performance of Executive’s duties hereunder, including but not limited to making any material misrepresentations to the Company (iii) Executive willfully engaging in conduct materially detrimental to the business of Interlink Electronics or (iv) Executive being convicted of a crime involving moral turpitude.

 

9.5                               Termination by Executive for Good Reason. Executive may terminate his employment by written notice to Interlink Electronics for “Good Reason,” as defined below. “Good Reason” means one or more of the following: (1) Executive’s assignment by Interlink Electronics, without Executive’s written consent, to duties or responsibilities which are not consistent with that of duties and responsibilities as set forth herein; (2) reduction by Interlink Electronics, without Executive’s written consent, of Executive’s salary and bonus pursuant to Section 4.1 and Section 4.3, above; or (3) Interlink Electronics’ material breach of its obligations under this Agreement, which breach has continued uncured for a period of thirty days after its receipt of written notice from Executive.

 

9.6                               Compensation in Event of Termination.

 

(a)                                 Voluntary Termination. Upon Executive’s voluntary termination of this Agreement pursuant to Section 9.1, Executive shall be entitled to receive the compensation, as set forth in paragraph 4 above, up to the date of termination, and after such date shall not be entitled to any Compensation under this Agreement, and Executive will no longer continue any vesting but instead will retain any equity that has vested as of the date of termination.

 

(b)                                 Termination for Death or Disability. If Executive’s employment is terminated due to the Executive’s Death or Disability pursuant to Sections 9.2 or 9.3, then Executive or his beneficiaries will be entitled to receive: (i) Executive’s Compensation, as set forth in Section 4, above, to the end of the monthly pay period immediately following Executive’s date of termination, (ii) accrued Bonus Payments payable to the Executive under the Management Bonus Plan and (iii) all equity and/or options issued to Executive by Interlink Electronics but not yet vested shall is immediately fully vest.

 

5

 

(c)                                  Termination for Cause. Upon the termination of this Agreement pursuant to Section 9.4, the Executive shall be entitled to receive his Compensation, as set forth in paragraph 4, above, to the date of termination, and after such date shall not be entitled to any Compensation, benefits or other rights granted herein to the Executive.

 

(d)                                 Termination by Executive for Good Reason or by Interlink Electronics Without Cause. If executive’s employment is terminated by the Executive for Good Reason pursuant to Section 9.5, or by Interlink Electronics without cause, then Executive will be entitled to receive: (1) Executive’s Compensation, as set forth in Section 4, above, to the date of termination; (2) a severance payment equal to twelve (12) months of Executive’s Compensation, as set forth in Section 4, above; (3) bonus compensation earned by Executive pursuant to Section 4.3, above; (4) benefits, pursuant to Section 4.4, above, for twelve (12) months following the date of termination; (5) any vested company match 401k or other retirement contribution; and (6) all equity or options issued to Executive by Interlink Electronics but not yet vested shall is immediately fully vest.

 

9.7                               Release. In no event shall the Executive be entitled to receive any payments, amounts, rights, or benefits under this Section 9 unless Executive executes a release concerning any claims Executive may have against Interlink Electronics in a form reasonably acceptable to Interlink Electronics.

 

10.                               Change In Control Provision. In the event there occurs a change in control with respect to Interlink Electronics then the Executive shall be entitled to receive a change in control payment in an amount equal to one (1) times the Executive’s then annual salary, payable upon the date the “change in control” occurs. Additionally, upon a Change in Control any equity securities or options held by the Executive that are subject to a vesting period, shall immediately fully vest. For the purposes of this Section 10 “Change In Control” shall mean the consummation of any of the following transactions effecting a change in ownership or control of the Company: (i) a merger, consolidation or reorganization, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Company’s outstanding voting securities immediately prior to such transaction; or (ii) any transfer, sale or other disposition of all or substantially all of the Company’s assets; or (iii) the acquisition, directly or indirectly by any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company), of beneficial ownership (within the meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as amended) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities pursuant to a tender or exchange offer made directly to the Company’s beneficial holders. In no event, however, shall a Change in Control be deemed to occur in connection with (i) a merger of the Company, the sole purpose of which is to reincorporate the Company in another jurisdiction, or (ii) any public offering of Common Stock, the primary purpose of which is to raise capital; or (iii) an increase or decrease of the Executive’s beneficial ownership in the Company.

 

6

 

11.                               Miscellaneous.

 

11.1                        Survival. The provisions of Sections 7, 8 and 9 shall survive the termination of this Agreement.

 

11.2                        Entire Agreement. This Agreement sets forth the entire understanding of the Parties relating to the Executive’s employment with Interlink Electronics and merges and supersedes any prior or contemporaneous agreements between the Parties pertaining to the subject matter hereof, including, without limitation, that certain Employment Agreement, dated July 13, 2010, between Executive and the Company, which prior agreement is terminated.

 

11.3                        Modification. This Agreement may not be modified unless in writing and signed by the Party against whom the same is sought to be enforced.

 

11.4                        Waiver. Failure of a Party to enforce one or more of the provisions of this Agreement or to require at any time performance of any of the obligations hereof shall not be construed to be a waiver of such provisions by such Party nor to in any way affect the validity of this Agreement or such Party’s right thereafter to enforce any provision of this Agreement, nor to preclude such Party from taking any other action at any time which it would legally be entitled to take.

 

11.5                        Assignment. This Agreement and all any rights or obligations hereunder are not assignable by Executive, but may be assigned by Interlink Electronics upon the sale of substantially all of its assets.

 

11.6                        Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and transmitted via email, and shall be deemed to have been given at the time of transmittal, as follows:

 

	
To Company:
    	
Interlink   Electronics Inc.
    
	
 
    	
31248   Oak Crest Drive, Suite 110
    
	
 
    	
Westlake   Village, California 91361
    
	
 
    	
Attn.:   Frank Levinson, Chairman
    
	
 
    	
Compensation   Committee
    
	
 
    	
 
    
	
To Executive:
    	
Steven   N. Bronson
    
	
 
    	
 
    
	
 
    	
 
    

 

11.7                        Severability. If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, such invalidity or unenforceability shall not affect the validity and enforceability of the other provisions of this Agreement, and the provision held to be invalid or unenforceable shall be modified so as to be enforced as nearly as possible according to its original terms and intent but only to the extent necessary to eliminate such invalidity or 1menforceability.

 

11.8                        Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California.

 

7

 

11.9                        Counterparts. This Agreement may be executed in any number of counterparts, including facsimile and email pdf signatures which shall be deemed as original signatures. All executed counterparts shall constitute one agreement, notwithstanding that all signatories are not signatories to the original or the same counterpart.

 

[Signature Page Follows]

 

8

 

IN WITNESS WHEREOF, each Party hereto has duly executed this Agreement as of the date herein first set forth above.

 

	
INTERLINK ELECTRONICS, INC.
    	
 
    	
STEVEN N. BRONSON
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/ Frank Levinson
    	
 
    	
/s/ Steven N. Bronson
    
	
Frank   Levinson, Chairman of the
    	
 
    	
Steven N. Bronson
    
	
Compensation Committee of Interlink   Electronics, Inc.Exhibit 10.2

 

AMENDED AND RESTATED FOUNDERS AGREEMENT

 

THIS AMENDED
AND RESTATED FOUNDERS AGREEMENT (this “Agreement”) entered into on July 11, 2016, shall be effective as of March 17, 2015 (the “Effective
Date”) by and between Fortress Biotech, Inc., a Delaware corporation (the “Founder”), and Checkpoint
Therapeutics, Inc. (the “Company”).

 

WHEREAS, Founder and
the Company previously entered into a Founders Agreement, dated March 17, 2015 (the “Existing Founders Agreement”);

 

WHEREAS, Founder formed
the Company on November 10, 2014, for the purpose of acquiring, licensing, developing and commercializing specialty pharmaceutical
products (the “Business”);

 

WHEREAS, the parties
hereto have requested that the Existing Founders Agreement be amended and restated, in its entirety, on the terms and subject to
the conditions set forth herein;

 

NOW, THEREFORE, in
consideration of the mutual representations, warranties, covenants and agreements contained in this Agreement, and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

		1.1	Formation of the Company. Founder has organized
and completed the formation of the Company, expended time and capital in such formation and identified specific assets the acquisition
of which would benefit the Company and its business purpose.

 

		1.2	In exchange for the consideration contained in paragraph
1.1:

 

		(a)	Founder shall receive 1,000,000 shares of Common Stock
of the Company;

 

		(b)	Company shall assume all of Founder’s liabilities,
obligations, rights, title and interest in that certain indebtedness described on Schedule A (the “Indebtedness”);

 

		(c)	Founder shall receive an annual equity fee during the Term
payable in shares of Common Stock, such that on an annual basis on the anniversary of this Agreement, the Company shall issue
the Founder shares of Common Stock of the Company equal to two and a half percent (2.5%) of the fully-diluted outstanding
equity of the Company at the time of issuance; and

 

     

     

    

 

		(d)	Founder shall receive an equity fee during the Term payable
in shares of Common Stock equal to two and a half percent (2.5%) of the gross amount of any equity or debt financing, payable
within five (5) business days of the closing of any equity or debt financing for the Company or any of its respective subsidiaries
that occurs after the date hereof and ending on the date when Founder no longer has majority voting control in Company’s
voting equity. In calculating the number of shares payable hereunder, in the case of an equity financing, the number of shares
issuable will be based on the share price of the equity in such round; and (ii) in the case of a debt financing, the number of
shares issuable will be based on the closing price of the common shares of the company on the day prior to the closing of the
debt financing or if not publicly-traded, the price of the common shares in the last equity financing.

 

		(e)	In the event of a Change in Control, Founder shall receive
a one-time change in control fee equal in cash to five times the product of (i) Net Sales (defined below) for the twelve (12)
months immediately preceding the change in control and (ii) 4.5%.

 

Upon the Company’s satisfaction
of its obligations of (e)(i) and (e)(ii), Founder shall notify the Company in writing within fifteen days (15) of receipt of final
payment. At that time, Founder shall have the right to audit the Company’s financials, on terms mutually agreeable to the
parties, within thirty (30) days of the Company’s receipt of Founder’s request to audit. If Founder fails to request
an audit within thirty (30) days of what is marked as the Company’s final payment, it shall be deemed waived. If the audit
demonstrates that the Company satisfied all of its financial obligations to Founder, then this Agreement shall be terminated in
its entirety.

 

For purposes of this Agreement,
“Change of Control” shall mean the occurrence of any of the following events:

 

    2 

     

    

 

(i) during any consecutive 12-month
period, individuals who, at the beginning of such period, constitute the board of directors of the Company (the “Incumbent
Directors”) cease for any reason to constitute at least a majority of such Board, provided that any person becoming a director
after the beginning of such 12-month period and whose election or nomination for election was approved by a vote of at least a
majority of the Incumbent Directors then on the Board shall be an Incumbent Director; provided, however, that no
individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest
with respect to the election or removal of directors (“Election Contest”) or other actual or threatened solicitation
of proxies or consents by or on behalf of any “person” (as such term is defined in Section 3(a)(9) of the Securities
Exchange Act of 1934 (the “1934 Act”) and as used in Section 13(d)(3) and 14(d)(2) of the 1934 Act) other than the
Board (“Proxy Contest”), including by reason of any agreement intended to avoid or settle any Election Contest or Proxy
Contest, shall be deemed an Incumbent Director;

 

(ii) any person becomes a “beneficial
owner” (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of either (A) 35% or more of the then-outstanding
shares of common stock of the Company (“Company Common Stock”) or (B) securities of the Company representing 35% or
more of the combined voting power of the Company’s then-outstanding securities eligible to vote for the election of directors
(the “Company Voting Securities”); provided, however, that for purposes of this subsection (ii), the
following acquisitions of Company Common Stock or Company Voting Securities shall not constitute a Change of Control: (i) an acquisition
directly from the Company, (ii) an acquisition by the Company or any corporation, limited liability company, partnership or other
entity of which a majority of the outstanding voting stock or voting power is beneficially owned directly or indirectly by the
Company (a “Subsidiary”), (iii) an acquisition by any employee benefit plan (or related trust) sponsored or maintained
by the Company or any Subsidiary, or (iv) an acquisition pursuant to a Non-Qualifying Transaction (as defined in subsection (iii)
below);

 

    3 

     

    

 

(iii) the consummation of a
reorganization, merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company
or a subsidiary (a “Reorganization”), or the sale or other disposition of all or substantially all of the Company’s
assets (a “Sale”) or the acquisition of assets or stock of another corporation or other entity (an “Acquisition”),
unless immediately following such Reorganization, Sale or Acquisition: (A) all or substantially all of the individuals and entities
who were the beneficial owners, respectively, of the outstanding Company Common Stock and outstanding Company Voting Securities
immediately prior to such Reorganization, Sale or Acquisition beneficially own, directly or indirectly, more than 35% of, respectively,
the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to
vote generally in the election of directors, as the case may be, of the entity resulting from such Reorganization, Sale or Acquisition
(including, without limitation, an entity which as a result of such transaction owns the Company or all or substantially all of
the Company’s assets or stock either directly or through one or more subsidiaries, the “Surviving Entity”) in
substantially the same proportions as their ownership, immediately prior to such Reorganization, Sale or Acquisition, of the outstanding
Company Common Stock and the outstanding Company Voting Securities, as the case may be, and (B) no person (other than (x) the Company
or any Subsidiary, (y) the Surviving Entity or its ultimate parent entity, or (z) any employee benefit plan (or related trust)
sponsored or maintained by any of the foregoing) is the beneficial owner, directly or indirectly, of 35% or more of the total common
stock or 35% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Surviving
Entity, and (C) at least a majority of the members of the board of directors of the Surviving Entity were Incumbent Directors at
the time of the Board’s approval of the execution of the initial agreement providing for such Reorganization, Sale or Acquisition
(any Reorganization, Sale or Acquisition which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed
to be a “Non-Qualifying Transaction”); or

 

(iv) approval by the stockholders
of the Company of a complete liquidation or dissolution of the Company.

 

		(f)	Founder shall receive a cash fee during the Term equal
to four percent (4.5%) of annual Net Sales, payable on an annual basis, within 90 days of the end of each calendar year. For purposes
of this Agreement, “Net Sales” shall mean the gross amount invoiced or otherwise charged by Company, its Affiliates
and Licensees (“Selling Party”) to third parties in arm’s length transactions for sales of any
Product during a calendar year, less:

 

(i)          Normal
and customary trade, quantity, cash and discounts and credits allowed and taken;

 

    4 

     

    

 

(ii)         Discounts,
refunds, rebates, chargebacks, retroactive price adjustments, and any other allowances given and taken which effectively reduce
the net selling price (other than such which have already diminished the gross amount invoiced such as those outlined in Section
1.2(f)(i) above), including, without limitation, Medicaid rebates, institutional rebates or volume discounts;

 

(iii)        Product
returns and allowances granted to such third party;

 

(iv)        Administrative
fees paid to group purchasing organizations (e.g., Medicare) and government-mandated rebates;

 

(v)         Shipping,
handling, freight, postage, insurance and transportation charges, but all only to the extent included as a separate line item in
the gross amount invoiced;

 

(vi)        Any
tax, tariff or duties imposed on the production, sale, delivery or use of the Product, including, without limitation, sales, use,
excise or value added taxes and customs and duties, but all only to the extent included as a separate line item (e.g., “taxes”)
in the gross amount invoiced; and

 

(vii)       Bad
debt actually written off during the accounting period, as reported by the Selling Party in accordance with GAAP, applied on a
consistent basis (provided, that any bad debt write-off so taken which is later reversed shall be added back to Net Sales in the
accounting period in which the reversal occurs.)

 

Products are considered “sold”
when billed out or invoiced or, in the event such Products are not billed out or invoiced, when the consideration for sale of the
Products is received. If a sale, transfer or other disposition with respect to Products involves consideration other than cash
or is not at arm’s length, then the Net Sales from such sale, transfer or other disposition shall be calculated from the
average selling price for such Product during the calendar quarter in the country where such sale, transfer or disposition took
place. Notwithstanding the foregoing, Net Sales shall not include, and shall be deemed zero with respect to, (i) Products used
by Company, its Affiliates, or Licensees for their internal use, (ii) the distribution of promotional samples of Products provided
free of charge, (iii) Products provided for clinical trials or research, development, or evaluation purposes, or (iv) sales of
Products among Company and its Licensees and their respective Affiliates for resale.

 

    5 

     

    

 

“Product” means any
product, (i) owned by Company or (ii) exclusively licensed to Company. “License” means granting a third party or Affiliate
a right to make, have made, use, offer for sale, sell or import a Product.

 

“Licensee” means
a person or entity granted a License.

 

Reports;
Audits:

 

(A)         Within
ninety (90) days following the last day of each calendar year, Company shall provide to Founder a written statement (i) stating
(as applicable) the aggregate Net Sales, by country, of each Product sold during the relevant calendar year by Company, its Affiliates
and Licensees, and (ii) detailing the calculation of amounts due pursuant to Section 1.2(f) for such calendar year.

 

(B)         Company
shall keep or cause to be kept such records as are reasonably required to determine the amounts due under this Agreement; such
records must be kept for a minimum of three (3) years following the calendar year to which such records pertain. At the request
(and expense) of Founder, Company shall permit Founder to engage an independent certified public accounting firm reasonably acceptable
to Company, at reasonable times not more than once a year and upon reasonable notice, to examine only those records as may be necessary
to determine, with respect to any calendar year ending not more than three (3) years prior to Founder’s request, the correctness
or completeness of any payment made under this Agreement. Founder shall promptly provide a copy of the results of any such audit
or examination to Company. Founder shall bear the full cost of the performance of any such audit or examination, unless such audit
or examination discloses an underpayment exceeding ten percent (10%) of the amount actually due hereunder with respect to any particular
calendar year, in which case Company shall bear the reasonable, documented cost of the performance of such audit or examination.
Company shall promptly pay to Founder the amount of any underpayment of royalties revealed by such an examination and review. Any
overpayment by Company revealed by an examination and review shall be refunded to Company within thirty (30) calendar days of its
request.

 

2.           Representations
and Warranties of the Parties. Each of the parties hereto hereby represents and warrants to the other as follows:

 

2.1           Each
party may execute, deliver, and perform this Agreement without the necessity of obtaining any consent, approval, authorization,
registration, filing, or waiver or giving any notice, other than those already obtained;

 

    6 

     

    

 

2.2           This
Agreement has been duly authorized by all necessary actions of the party and constitutes the legal, valid, and binding obligation
of such party; and

 

2.3           Each
party has the full right, power, and authority to enter into this Agreement and to consummate the transactions contemplated hereby.

 

3.          Notices.
All notices hereunder must be in writing and will be deemed to have been duly given upon receipt of hand delivery, upon electronic
transmission with confirmation of receipt, or upon receipt of registered mail, return receipt requested, addressed to the address
set forth for each party, respectively, on the signature page of this Agreement or to such other address as may be designated by
written notice.

 

4.          Entire
Agreement. This Agreement constitutes the entire agreement of the parties with respect to the transactions contemplated
herein. All prior agreements among the parties concerning the subject matter hereof, whether written or oral, are merged herein
and shall be of no force or effect. This Agreement cannot be altered, modified, or discharged orally but only by an agreement in
writing.

 

5.          Benefit.
This Agreement shall be binding upon and shall inure to the benefit of the parties, their legal representatives, and assigns.

 

6.          Severability.
 If any provision contained in this Agreement is or becomes invalid, illegal, or unenforceable in any respect, the validity,
legality, and enforceability of the remaining provisions contained herein will not in any way be affected or impaired thereby.

 

7.          Further
Assurances. The parties hereby agree to execute and deliver such further instruments and do such further acts as may be
required to carry out the intent and purposes of this Agreement.

 

8.          Counterparts.
This Agreement may be executed separately by each party in multiple originals, and each original of this Agreement separately
executed by one party, when assembled with one or more copies of this Agreement separately executed by the other parties, shall
be and constitute a fully executed original of this Agreement.

 

9.          Survival.
All representations and warranties made herein by the parties will survive the execution of this Agreement.

 

10.        Governing
Law. This Agreement shall be governed by and construed in accordance with the substantive laws of the state of New York,
without giving effect to any choice of law or conflict of law provision or rule that would cause the application of the laws of
any jurisdiction other than the state of New York.

 

    7 

     

    

 

11.        Term.
This Agreement shall be in effect for a period equal to fifteen (15) years from the Effective Date (the “Initial Term”).
Upon expiration of the Initial Term, this Agreement shall be automatically renewed for successive periods of one (1) year (together
with the Initial Term, the “Term”), unless terminated by Founder by a letter sent by recorded delivery to the Company
at least six (6) months prior to the end of the contractual period in force. In the event of Change in Control, as defined by this
Agreement, termination is governed in accordance with that provision and subject to the one-time change in control fee.

 

12.        Amendment
and Restatement. The terms and provisions of the Existing Founders Agreement are hereby amended and restated in their entirety
by the terms and provisions of this Amended and Restated Founders Agreement and shall supersede all provisions of the Existing
Founders Agreement as of the date hereof. From and after the date hereof, all references made to the Existing Founders Agreement
in any document shall, without more, be deemed to refer to this Amended and Restated Founders Agreement.

 

    8 

     

    

 

IN WITNESS WHEREOF,
this Agreement has been duly executed by the parties effective for all purposes as of the date first written above.

 

	FORTRESS BIOTECH, INC.	 
	 	 
	By:	/s/ Lindsay A. Rosenwald	July 11, 2016
	Name:	Lindsay A. Rosenwald, MD	 
	Title:	President	 
	 	 
	Address for Notice:	 
	2 Gansevoort St	 
	New York, NY 10014	 
	 	 
	CHECKPOINT THERAPEUTICS, INC.	 
	 	 
	By:	/s/ James F. Oliviero	July 11, 2016
	Name:	James F. Oliviero	 
	Title:	Chief Executive Officer and President	 
	 	 
	Address for Notice:	 
	2 Gansevoort St	 
	New York, NY 10014	 

 

    9 

     

    

 

SCHEDULE A

 

Indebtedness

 

		1.	Promissory Note, with an issuance date of February, 27,
2015, and an execution date of July 30, 2015, in the original principal amount of $2,350,917, issued by Checkpoint Therapeutics,
Inc. to the order of NSC Biotech Venture Fund I, LLC.

 

    10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}]]